Moderna Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	6,848	19,263	18,471	803	60	135.07	205.83	108.4
Revenue Growth (YoY)	-64.45%	4.29%	2200.25%	1238.33%	-55.58%	-34.38%	89.88%	-
Cost of Revenue	4,693	5,416	2,617	8	0	0	0	0
Gross Profit	2,155	13,847	15,854	795	60	135.07	205.83	108.4
Selling, General & Admin	1,549	1,132	567	188	110	94.25	64.72	57.45
Research & Development	4,845	3,295	1,991	1,370	496	454.08	410.46	274.72
Operating Expenses	6,394	4,427	2,558	1,558	606	548.33	475.18	332.17
Operating Income	-4,239	9,420	13,296	-763	-546	-413.27	-269.36	-223.77
Other Expense / Income	-297	-155	11	-19	-31	-28.86	-13.36	-8.6
Pretax Income	-3,942	9,575	13,285	-744	-515	-384.41	-256	-215.17
Income Tax	772	1,213	1,083	3	-1	0.33	-0.08	1.04
Net Income	-4,714	8,362	12,202	-747	-514	-384.73	-255.92	-216.21
Preferred Dividends	0	0	0	0	0	17.12	13.93	14.1
Net Income Common	-4,714	8,362	12,202	-747	-514	-401.86	-269.84	-230.31
Net Income Growth	-	-31.47%	-	-	-	-	-	-
Shares Outstanding (Basic)	382	394	403	381	331	81	64	61
Shares Outstanding (Diluted)	382	416	431	381	331	81	64	61
Shares Change	-8.17%	-3.48%	13.12%	15.11%	308.07%	25.76%	6.17%	-
EPS (Basic)	-12.33	21.26	30.31	-1.96	-1.55	-4.95	-4.18	-3.79
EPS (Diluted)	-12.33	20.12	28.29	-1.96	-1.55	-4.95	-4.18	-3.79
EPS Growth	-	-28.88%	-	-	-	-	-	-
Free Cash Flow	-3,825	4,581	13,336	1,959	-491	-436.63	-389.89	33.59
Free Cash Flow Per Share	-10.01	11.63	33.09	5.14	-1.48	-5.38	-6.04	0.55
Gross Margin	31.47%	71.88%	85.83%	99.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-61.90%	48.90%	71.98%	-95.02%	-910.00%	-305.97%	-130.87%	-206.44%
Profit Margin	-68.84%	43.41%	66.06%	-93.03%	-856.67%	-297.52%	-131.10%	-212.47%
Free Cash Flow Margin	-55.86%	23.78%	72.20%	243.96%	-818.33%	-323.27%	-189.43%	30.99%
Effective Tax Rate	-	12.67%	8.15%	-	-	-	-	-
EBITDA	-3,321	9,923	13,517	-651	-484	-359.55	-235.46	-200.05
EBITDA Margin	-48.50%	51.51%	73.18%	-81.07%	-806.67%	-266.20%	-114.40%	-184.56%
Depreciation & Amortization	621	348	232	93	31	24.86	20.54	15.11
EBIT	-3,942	9,575	13,285	-744	-515	-384.41	-256	-215.17
EBIT Margin	-57.56%	49.71%	71.92%	-92.65%	-858.33%	-284.60%	-124.38%	-198.50%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).